Trust Co. of Toledo NA OH continued to hold its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent filing with the SEC. The fund owned 13,767 shares of the medical instruments supplier’s stock at the end of the second quarter. Trust Co. of Toledo NA OH’s holdings in DENTSPLY SIRONA were worth $893,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. RMB Capital Management LLC boosted its stake in shares of DENTSPLY SIRONA by 47.3% in the fourth quarter. RMB Capital Management LLC now owns 50,802 shares of the medical instruments supplier’s stock valued at $2,933,000 after buying an additional 16,317 shares during the period. UBS Asset Management Americas Inc. boosted its stake in shares of DENTSPLY SIRONA by 5.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 984,180 shares of the medical instruments supplier’s stock valued at $56,817,000 after buying an additional 49,439 shares during the period. Teachers Advisors LLC boosted its stake in shares of DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock valued at $18,657,000 after buying an additional 50,432 shares during the period. Kentucky Retirement Systems purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $967,000. Finally, Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $432,000. 94.97% of the stock is currently owned by hedge funds and other institutional investors.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 61.59 on Monday. The firm’s 50-day moving average price is $63.88 and its 200 day moving average price is $62.25. DENTSPLY SIRONA Inc. has a 52 week low of $55.00 and a 52 week high of $65.68. The company has a market capitalization of $14.12 billion, a PE ratio of 39.63 and a beta of 1.26.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 EPS for the quarter, missing the Zacks’ consensus estimate of $0.50 by $0.01. The business had revenue of $900.50 million during the quarter, compared to analyst estimates of $916.55 million. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The firm’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.69 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post $2.84 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.57%. DENTSPLY SIRONA’s payout ratio is 22.58%.

TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/07/trust-co-of-toledo-na-oh-maintains-position-in-dentsply-sirona-inc-nasdaqxray-updated-updated-updated.html.

XRAY has been the topic of several research reports. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th. Goldman Sachs Group Inc cut DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $60.00 to $55.00 in a report on Tuesday, May 23rd. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. BidaskClub cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. Finally, HC Wainwright initiated coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $67.92.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.